随机试点研究比较基于DCB与基于DST的策略,用于治疗真实或复杂的冠状动脉分支病变
Dan Ke1,2, Xi He1,2, Canqiang Chen1,2
1Department of Cardiology, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
药物涂层气球 (DCB) 单独提供了一种安全有效的替代方案,用于双支架技术 (DST) 治疗精选的真正分叉病变 (TBLs),显示减少晚期光损失,而不影响其他关键结果.
科学领域:
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
- 医疗器械 医疗器械
背景情况:
- 双支架技术 (DST) 是真正的分叉病变 (BL) 的标准,但药物涂层气球 (DCB) 单疗法提供了一个不那么侵入性的替代方案.
- 对真正的BLs仅使用DCB处理存在对程序安全的担忧.
研究的目的:
- 评估仅使用DCB的策略与用于治疗真正分叉病变 (TBLs) 的DST的策略的安全性和有效性.
主要方法:
- 一个随机试验,涉及60名患有TBL的患者,将基于DCB的策略与基于DST的策略进行比较.
- 主要终点包括1年的晚期光损失 (LLL) 和主要不良心脏事件 (MACE).
- 二级终点包括最小光线直径,直径狭窄,二进制复缩和MACE组件.
主要成果:
- 与DST相比,DCB集团在主要和侧支行中显示出明显较低的一年LLL.
- 在两组之间,最小光线直径,直径狭窄和目标损伤再血管化率是可比的.
- 一年累积的MACE率低且相似,主要是由目标病变重血管化驱动的,在任何组中都没有心脏死亡,TVMI或TVT.
结论:
- 与DST策略相比,基于DCB的策略似乎是与DST策略相比,对于选择的真双叉病变来说,是一种安全有效的选择.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...